Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Three-Hour online class help families manage bladder and bowel issues in duchenne muscular dystrophy?

NCT ID NCT07821125

Symptom relief Sponsor: Lokman Hekim University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 15, 2026 · Last updated Sep 16, 2026 · Updated 1 time

Summary

Researchers are testing whether a single online urotherapy education session can improve parents' knowledge and daily habits around bladder and bowel care for children with Duchenne muscular dystrophy. About 50 parents or caregivers will take part. The session covers urinary tract function, toileting posture, scheduled voiding, fluid intake, and lifestyle changes. Parents complete knowledge tests before, right after, and two weeks later, and they report on satisfaction and any changes in daily routines.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
urotherapy education, a structured teaching session on bladder and bowel habits
What this could lead to
If it works, this could give families a low-cost, online way to manage bladder and bowel symptoms that often come with Duchenne muscular dystrophy.
What could go wrong
This is a small, early study with no control group, so improvements may reflect parents' general interest rather than the education itself. The results may not apply to families who cannot attend online sessions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being a parent or caregiver of a child diagnosed with Duchenne muscular dystrophy. * Volunteering to participate in the study. * Providing informed consent. * Being able to participate in the online urotherapy education and complete the study assessments. Exclusion Criteria: * Not completing the urotherapy education session. * Not completing the required study assessments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Duchenne muscular dystrophy (DMD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Duchenne muscular dystrophy Lower Urinary Tract Symptoms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Duchenne muscular dystrophy (DMD) Lower urinary tract symptoms (LUTS)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Lokman Hekim University, Ankara, Ankara

    Ankara, Ankara, 06370, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.